1. Home
  2. TBN vs ANGO Comparison

TBN vs ANGO Comparison

Compare TBN & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBN
  • ANGO
  • Stock Information
  • Founded
  • TBN 2009
  • ANGO 1988
  • Country
  • TBN Australia
  • ANGO United States
  • Employees
  • TBN N/A
  • ANGO N/A
  • Industry
  • TBN
  • ANGO Medical/Dental Instruments
  • Sector
  • TBN
  • ANGO Health Care
  • Exchange
  • TBN NYSE
  • ANGO Nasdaq
  • Market Cap
  • TBN 284.5M
  • ANGO 271.1M
  • IPO Year
  • TBN 2024
  • ANGO 2004
  • Fundamental
  • Price
  • TBN $19.11
  • ANGO $7.20
  • Analyst Decision
  • TBN Buy
  • ANGO Strong Buy
  • Analyst Count
  • TBN 3
  • ANGO 4
  • Target Price
  • TBN $34.67
  • ANGO $12.00
  • AVG Volume (30 Days)
  • TBN 18.4K
  • ANGO 527.8K
  • Earning Date
  • TBN 11-15-2024
  • ANGO 01-03-2025
  • Dividend Yield
  • TBN N/A
  • ANGO N/A
  • EPS Growth
  • TBN N/A
  • ANGO N/A
  • EPS
  • TBN N/A
  • ANGO N/A
  • Revenue
  • TBN N/A
  • ANGO $292,726,000.00
  • Revenue This Year
  • TBN N/A
  • ANGO N/A
  • Revenue Next Year
  • TBN N/A
  • ANGO $7.69
  • P/E Ratio
  • TBN N/A
  • ANGO N/A
  • Revenue Growth
  • TBN N/A
  • ANGO N/A
  • 52 Week Low
  • TBN $17.48
  • ANGO $5.26
  • 52 Week High
  • TBN $25.99
  • ANGO $8.25
  • Technical
  • Relative Strength Index (RSI)
  • TBN N/A
  • ANGO 56.31
  • Support Level
  • TBN N/A
  • ANGO $6.61
  • Resistance Level
  • TBN N/A
  • ANGO $7.46
  • Average True Range (ATR)
  • TBN 0.00
  • ANGO 0.33
  • MACD
  • TBN 0.00
  • ANGO 0.08
  • Stochastic Oscillator
  • TBN 0.00
  • ANGO 73.74

About TBN TAMBORAN RESOURCES CORPORATION

Tamboran Resources Corp is a gas company focused on supporting the Net Zero CO2 energy transition in Australia and Asia-Pacific through developing low CO2 unconventional gas resources in the Australian Northern Territory.

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Share on Social Networks: